Crossman AR - Search Results

1

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.

Crossman AR. Crossman AR. Mov Disord. 1990;5(2):100-8. doi: 10.1002/mds.870050203. Mov Disord. 1990. PMID: 1970120 Review.

2

Chemical signalling in the globus pallidus in parkinsonism.

Brotchie J, Crossman A, Mitchell I, Duty S, Carroll C, Cooper A, Henry B, Hughes N, Maneuf Y. Brotchie J, et al. Prog Brain Res. 1993;99:125-39. doi: 10.1016/s0079-6123(08)61342-4. Prog Brain Res. 1993. PMID: 7906423 Review. No abstract available.

3

Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease.

Maneuf YP, Duty S, Hille CJ, Crossman AR, Brotchie JM. Maneuf YP, et al. Among authors: crossman ar. Exp Neurol. 1996 May;139(1):12-6. doi: 10.1006/exnr.1996.0075. Exp Neurol. 1996. PMID: 8635558

4

[3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: abnormalities in discrete brain regions of the motor system.

Richter A, Brotchie JM, Crossman AR, Löscher W. Richter A, et al. Among authors: crossman ar. Mov Disord. 1998 Jul;13(4):718-25. doi: 10.1002/mds.870130419. Mov Disord. 1998. PMID: 9686781

5

The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.

Robertson RG, Clarke CA, Boyce S, Sambrook MA, Crossman AR. Robertson RG, et al. Among authors: crossman ar. Brain Res. 1990 Oct 29;531(1-2):95-104. doi: 10.1016/0006-8993(90)90762-z. Brain Res. 1990. PMID: 2289139

6

Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.

Fox SH, Henry B, Hill M, Crossman A, Brotchie J. Fox SH, et al. Mov Disord. 2002 Nov;17(6):1180-7. doi: 10.1002/mds.10289. Mov Disord. 2002. PMID: 12465055

7

Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease.

Fox S, Silverdale M, Kellett M, Davies R, Steiger M, Fletcher N, Crossman A, Brotchie J. Fox S, et al. Mov Disord. 2004 May;19(5):554-60. doi: 10.1002/mds.10693. Mov Disord. 2004. PMID: 15133820 Clinical Trial.

8

Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia.

Bourdenx M, Nilsson A, Wadensten H, Fälth M, Li Q, Crossman AR, Andrén PE, Bezard E. Bourdenx M, et al. Among authors: crossman ar. Neurobiol Dis. 2014 Feb;62:307-12. doi: 10.1016/j.nbd.2013.10.016. Epub 2013 Oct 19. Neurobiol Dis. 2014. PMID: 24148855

9

Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.

Kobylecki C, Crossman AR, Ravenscroft P. Kobylecki C, et al. Among authors: crossman ar. Exp Neurol. 2013 Sep;247:476-84. doi: 10.1016/j.expneurol.2013.01.019. Epub 2013 Jan 27. Exp Neurol. 2013. PMID: 23360800

10

Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia.

Guigoni C, Li Q, Aubert I, Dovero S, Bioulac BH, Bloch B, Crossman AR, Gross CE, Bezard E. Guigoni C, et al. Among authors: crossman ar. J Neurosci. 2005 Feb 23;25(8):2102-7. doi: 10.1523/JNEUROSCI.5059-04.2005. J Neurosci. 2005. PMID: 15728850 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results